AMBALAL SARABHAI ENTERPRISES LTD. - Announcement Under Regulation 30 Of SEBI(LODR) Regulations,2015 - Outcome Of The Meeting Of Board Of Directors Held On 02.01.2021
Download 
|
< Back |
| 02 Jan 2021 | |
| In continuation to our corporate disclosure dated 26th November,2020 which was filed with exchange on 26th November,2020 and in line with the corporate disclosure requirement under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform that :<BR> <BR> Board of Directors of the Company had in its meeting held on 2nd January,2021, inter-alia, has approved the extension up to 28.02.2021 for completion of sale / disposal in pursuant to Share Purchase Agreement (SPA) executed with Asence Pharma Private Limited for sale of equity shares of Synbiotics Limited, a wholly owned subsidiary to Asence Pharma Private Limited, another subsidiary of the Company on consideration of Rs. 11,91,87,640/-(Rupees Eleven Crores Ninety One Lakh Eighty Seven Thousand Six Hundred Forty only). <BR> <BR> The detailed announcement has been attached herewith.<BR> <BR> Please take on your record and oblige.<BR> | |
| View all announcements for AMBALAL SARABHAI ENTERPRISES LTD. | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback